Randomized controlled multicnter CSII clinical trial for ATA-I-1-0 insulin pump in the intensive treatment of diabetes patients

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000029725

Enrollment

Unknown

Registered

2020-02-10

Start date

2017-10-25

Completion date

Unknown

Last updated

2020-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Interventions

Group 2:712 pump

Group 1:ATA-I-1-0 pump

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 75 years male or female; 2. Type 1 & type 2 diabetics, who need to use CSII; 3. HbA1c>=9.0%; 4. Haven't change therapy of Diabetes within past 30 days; 5. Patient willing to attend the clinical trial and signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. Patient who not suitable for CSII; 2. Diabetics who has serious circulatory disturbance; 3. Patient who has Serverous harm to haeart, liver or kidney; 4. Patient who have mental disease, acrasia, or can't express self clearly; 5. Patient who occuurded DKA or HNDC; 6. Pregnant or lactating patient, or who plan to pregnant; 7. Allergic condition patient or skin allergic to tape; 8. Haven't attend any clincal trial in past 3 months; 9. Not willing to follow the clincal trial portocal or researcher consider not suitable for the trial.

Design outcomes

Primary

Measure	Time frame
venous FBG;	—

Secondary

Measure	Time frame
HbA1C;BG;	—

Countries

China

Contacts

Public ContactMu Yimin

Chinese PLA General Hospital

muyiming@301hospital.com.cn+86 010-66939841

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026